参考文献/References:
[1]Camacho-Gonzalez A,Spearman PW,Stoll BJ.Neonatal infectious diseases:evaluation of neonatal sepsis[J].Pediatr Clin North Am,2013,60(2):367-389.[2]Puopolo KM,Eichenwald EC.No change in the incidence of ampicillin-resistant,neonatal,early-onset sepsis over 18 years[J].Pediatrics,2010,125(5):e1031-e1038.[3]段宝生,赵娜,梁超,等.降钙素原和超敏C反应蛋白联合检测在新生儿败血症早期诊断的价值研究[J].国际检验医学杂志,2014,24(20):2754-2755.[4]陈潇,富建华.新生儿败血症229例临床特点、病原学分布及转归分析[J].中华实用儿科临床杂志,2019,34(10):740-744.[5]Sharma D,Patel A,Soni P,et al.Leminorella sepsis in very low birth weight neonate as cause of neonatal mortality:First case report and literature review[J].The Journal of Maternal-Fetal&Neonatal Medicine,2016,6(29):1-3.[6]Sharma D,Dasi T,Murki S,et al.Kluyvera ascorbata sepsis in an extremely low birth weight infant[J].Indian J Med Microbiol,2015,33(3):437-439.[7]Shane AL,Sanchez PJ,Stoll BJ.Neonatal sepsis[J].Lancet,2017,390(10104):1770-1780.[8]高波,余加林.新生儿败血症超敏C反应蛋白诊断界值探讨[J].中国实用儿科杂志, 2012(12):902-905.[9]Mussap M,Noto A,Cibecchini F,et al.The importance of biomarkers in neonatology[J].Seminars in Fetal and Neonatal Medicine,2013,18(1):56-64.[10]Sharma D,Farahbakhsh N,Shastri S,et al.Biomarkers for diagnosis of neonatal sepsis:a literature review[J].J Matern Fetal Neonatal Med,2018,31(12):1646-1659.[11]张瑾,曲东,任晓旭,等.降钙素原对新生儿败血症病情及预后的评估[J].中华医学杂志,2018,98(16):1267-1272.[12]Lee J,Bang YH,Lee EH,et al.The influencing factors on procalcitonin values in newborns with noninfectious conditions during the first week of life[J].Korean Journal of Pediatrics,2017,60(1):10-16.[13]Kordek A,Loniewska B,Podraza W,et al.Usefulness of estimation of blood procalcitonin concentration versus C-reactive protein concentration and white blood cell count for therapeutic monitoring of sepsis in neonates[J].Postepy Hig Med Dosw,2014,21(68):1516-1523.[14]Wu F,Hou XQ,Sun RR,et al.The predictive value of joint detection of serum amyloid protein A,PCT,and Hs-CRP in the diagnosis and efficacy of neonatal septicemia[J].European Review for Medical and Pharmacological Sciences,2019:2313.[15]Hedegaard SS,Wisborg K,Hvas A-M.Diagnostic utility of biomarkers for neonatal sepsisa systematic review[J].Infect Dis Lond Engl,2015,47(3):117-124.[16]Hofer N,Zacharias E,Müller,et al.An Update on the Use of C-Reactive Protein in Early-Onset Neonatal Sepsis:Current Insights and New Tasks[J].Neonatology,2012,102(1):25-36.[17]Benitz WE.Adjunct laboratory tests in the diagnosis of early-onset neonatal sepsis[J].Clin Perinatol,2010,37(2):421-438.[18]周华佳.白细胞介素-6、降钙素原及C-反应蛋白在新生儿败血症早期诊断中的价值[J].检验医学与临床,2012(19):2428-2429.[19]Ganesan P,Shanmugam P,Sattar SBA,et al.Evaluation of IL-6,CRP and hs-CRP as Early Markers of Neonatal Sepsis[J].J Clin Diagn Res JCDR,2016,10(5):DC13-DC17.[20]Murphy K,Weiner J.Use of leukocyte counts in evaluation of early-onset neonatal sepsis DC[J].Pediatr Infect Dis J,2012,31(1):16-19.[21]Gerdes JS.Clinicopathologic approach to the diagnosis of neonatal sepsis[J].Clin Perinatol,1991,18(2):361-381.[22]Hornik CP,Fort P,Clark RH,et al.Early and late onset sepsis in very-low-birth-weight infants from a large group of neonatal intensive care units[J].Early Hum Dev,2012,5(88):S69-S74.[23]中华医学会儿科学分会新生儿学组,中华医学会中华儿科杂志编辑委员会.新生儿败血症诊疗方案[J].中华儿科杂志,2003,41(12):897-899.[24]Hornik CP,Benjamin DK,Becker KC,et al.Use of the complete blood cell count in early-onset neonatal sepsis[J].Pediatr Infect Dis J,2012,31(8):799-802.[25]Polin RA.Management of Neonates With Suspected or Proven Early-Onset Bacterial Sepsis[J].Pediatrics,2012,129(5):1006-1015.[26]Yuan H,Huang J,Lv B,et al.Diagnosis value of the serum amyloid A test in neonatal sepsis:a meta-analysis[J].BioMed Res Int,2013(2013):520294.[27]Wilfredo Colón,Aguilera JJ,Srinivasan S.Intrinsic Stability,Oligomerization,and Amyloidogenicity of HDL-Free Serum Amyloid A[J].Advances in Experimental Medicine and Biology,2015(855):117-134.[28]Arnon S,Litmanovitz I,Regev R,et al.The prognostic virtue of inflammatory markers during late-onset sepsis in preterm infants[J].J Perinat Med,2004,32(2):176-180.[29]Arnon S,Litmanovitz I,Regev RH,et al.Serum amyloid A:an early and accurate marker of neonatal early-onset sepsis[J].J Perinatol Off J Calif Perinat Assoc,2007,27(5):297-302.[30]Pavcnik-Arnol M,Hojker S,Derganc M.Lipopolysaccharide-binding protein in critically ill neonates and children with suspected infection:comparison with procalcitonin,interleukin-6,and C-reactive protein[J].Intensive Care Med,2004,30(7):1454-1460.[31]Turner D,Hammerman C,Rudensky B,et al.Procalcitonin in preterm infants during the first few days of life:introducing an age related nomogram[J].Arch Dis Child Fetal Neonatal Ed,2006,91(4):F283-F286.[32]Behrendt D.Lipopolysaccharide binding protein in preterm infants[J].Arch Dis Child Fetal Neonatal Ed,2004,89(6):F551-F554.[33]王丽平.白介素6在新生儿败血症早期诊断的应用[J].医药论坛杂志,2002(21):4.[34]Raynor LL,Saucerman JJ,Akinola MO,et al.Cytokine screening identifies NICU patients with Gram-negative bacteremia[J].Pediatr Res,2012,71(3):261-266.[35]Mehr S,Doyle LW.Cytokines as markers of bacterial sepsis in newborn infants:a review[J].Pediatr Infect Dis J,2000,19(9):879-887.[36]Qiu X,Zhang L,Tong Y,et al.Interleukin-6 for early diagnosis of neonatal sepsis with premature rupture of the membranes:A meta-analysis[J].Medicine,2018,97(47):e13146.[37]Hou T,Huang D,Zeng R,et al.Accuracy of serum interleukin(IL)-6 in sepsis diagnosis:a systematic review and meta-analysis[J].Int J Clin Exp Med,2015,8(9):15238-15245.[38]Franz AR,Sieber S,Pohlandt F,et al.Whole blood interleukin 8 and plasma interleukin 8 levels in newborn infants with suspected bacterial infection[J].Acta Paediatrica,2004,93(5):648-653.[39]Ng PC,Lam HS.Diagnostic markers for neonatal sepsis[J].Curr Opin Pediatr,2006,18(2):125-131.[40]Boskabadi H,Maamouri G,Afshari JT,et al.Serum interleukin 8 level as a diagnostic marker in late neonatal sepsis[J].Iran J Pediatr,2010,20(1):41-47.[41]曹霞,杨婕,李翠霞,等.血清PCT、TNF-α及sTNFR-Ⅱ在新生儿败血症中表达水平及临床意义[J].标记免疫分析与临床,2019(3):447-450.[42]Nupponen I,Andersson S,Jarvenpaa AL,et al.Neutrophil CD11b Expression and Circulating Interleukin-8 as Diagnostic Markers for Early-Onset Neonatal Sepsis[J].PEDIATRICS,2001,108(1):e12.[43]Fabriek BO,Dijkstra CD,Berg TKVD.The macrophage scavenger receptor CD163[J].Immunobiology,2005,210(2-4):0-160.[44]Dessi A,Liori B,Caboni P,et al.Monitoring neonatal fungal infection with metabolomics[J].J Matern Fetal Neonatal Med,2014,27(2):34-38.
相似文献/References:
[1]尹晓华,刘重元,黄 琳,等.胃癌中lncRNAs的研究进展[J].医学信息,2018,31(03):10.[doi:10.3969/j.issn.1006-1959.2018.03.004]
YIN Xiao-hua,LIU Zhong-yuan,HUANG Lin,et al.Research Progress of lncRNAs in Gastric Cancer[J].Medical Information,2018,31(06):10.[doi:10.3969/j.issn.1006-1959.2018.03.004]
[2]刘 坤,陈德春.基于生信学方法分析GSDM基因家族在膀胱癌的表达及临床意义[J].医学信息,2022,35(10):14.[doi:10.3969/j.issn.1006-1959.2022.10.003]
LIU Kun,CHEN De-chun.Expression and Clinical Significance of GSDM Gene Family in Bladder Cancer Based on Bioinformatics Analysis[J].Medical Information,2022,35(06):14.[doi:10.3969/j.issn.1006-1959.2022.10.003]
[3]陶碧君,刘建德,王玉洲.LncRNA FOXD3-AS1在恶性肿瘤中的表达、功能及作用机制[J].医学信息,2022,35(10):51.[doi:10.3969/j.issn.1006-1959.2022.10.012]
TAO Bi-jun,LIU Jian-de,WANG Yu-zhou.Expression, Function and Mechanism of LncRNA FOXD3-AS1 in Malignant Tumors[J].Medical Information,2022,35(06):51.[doi:10.3969/j.issn.1006-1959.2022.10.012]
[4]高程凤,孙 蕊.新生儿败血症致病菌分布及耐药性分析[J].医学信息,2018,31(17):116.[doi:10.3969/j.issn.1006-1959.2018.17.035]
GAO Cheng-feng,SUN Rui.Distribution and Drug Resistance of Pathogenic Bacteria in Neonatal Septicemia[J].Medical Information,2018,31(06):116.[doi:10.3969/j.issn.1006-1959.2018.17.035]
[5]余世纪,谢勇丽,苏晓清.血清VDBP、IL-8、sTWEAK与尿VDBP早期诊断糖尿病肾病的价值[J].医学信息,2019,32(09):38.[doi:10.3969/j.issn.1006-1959.2019.09.013]
YU Shi-ji,XIE Yong-li,SU Xiao-qing.The Value of Serum VDBP,IL-8,sTWEAK and Urine VDBP in Early Diagnosis of Diabetic Nephropathy[J].Medical Information,2019,32(06):38.[doi:10.3969/j.issn.1006-1959.2019.09.013]
[6]王清华,易守芳,余明芳.肾移植术后药源性肾损伤生物标志物的研究[J].医学信息,2019,32(10):44.[doi:10.3969/j.issn.1006-1959.2019.10.016]
WANG Qing-hua,YI Shou-fang,YU Ming-fang.Study on Biomarkers of Drug-induced Renal Injury after Renal Transplantation[J].Medical Information,2019,32(06):44.[doi:10.3969/j.issn.1006-1959.2019.10.016]
[7]黄琪峰,郑琳琳,张 菁.生物信息学分析筛选肺腺癌靶基因及评估预后的价值[J].医学信息,2019,32(22):62.[doi:10.3969/j.issn.1006-1959.2019.22.020]
HUANG Qi-feng,ZHENG Lin-lin,ZHANG Jing.Bioinformatics Analysis of Screening Lung Adenocarcinoma Target Genes and Evaluating Prognostic Value[J].Medical Information,2019,32(06):62.[doi:10.3969/j.issn.1006-1959.2019.22.020]
[8]孟 华,苏馨雅,陆雯雯,等.CHA2DS2-VASc评分联合生物标志物对非瓣膜性心房颤动并发脑卒中诊断价值的系统综述[J].医学信息,2023,36(19):179.[doi:10.3969/j.issn.1006-1959.2023.19.041]
MENG Hua,SU Xin-ya,LU Wen-wen,et al.A Systematic Review of the Diagnostic Value of CHA2DS2-VASc Score Combined with Biomarkers for Non-valvular Atrial Fibrillation Complicated by Stroke[J].Medical Information,2023,36(06):179.[doi:10.3969/j.issn.1006-1959.2023.19.041]
[9]林素梅,吕 聪,杨小叶,等.利奈唑胺治疗新生儿革兰阳性球菌败血症的疗效[J].医学信息,2020,33(05):142.[doi:10.3969/j.issn.1006-1959.2020.05.045]
LIN Su-mei,Lyu Cong,YANG Xiao-ye,et al.Effect of Linezolid in the Treatment of Neonatal Gram-positive Cocci Sepsis[J].Medical Information,2020,33(06):142.[doi:10.3969/j.issn.1006-1959.2020.05.045]
[10]胡 静,钟晓波,朱士胜,等.颞下颌关节骨关节病关节液的定量蛋白质组学研究[J].医学信息,2020,33(10):65.[doi:10.3969/j.issn.1006-1959.2020.10.019]
HU Jing,ZHONG Xiao-bo,ZHU Shi-sheng,et al.Quantitative Proteomics Study on Joint Fluid of Temporomandibular Joint Osteoarthropathy[J].Medical Information,2020,33(06):65.[doi:10.3969/j.issn.1006-1959.2020.10.019]